Increased Serum GP88 (Progranulin) Concentrations in Rheumatoid Arthritis

Inflammation

Volumn 37, Issue 5, 2014, Pages 1806-1813

  Yamamoto, Yasuko ^a   Takemura, Masao ^a,e   Serrero, Ginette ^b   Hayashi, Jun ^b   Yue, Binbin ^b   Tsuboi, Aya ^a   Kubo, Hisako ^a   Mitsuhashi, Takashi ^d   Mannami, Kenji ^d   Sato, Masao ^c   Matsunami, Hidetoshi ^a,e   Matuo, Yushi ^a   Saito, Kuniaki ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b A&G Pharmaceutical   (United States)

^c Matsunami General Hospital   (Japan)

^d Mannami Hospital   (Japan)

^e Matsunami Research Park   (Japan)

Author keywords

ELISA; GP88 progranulin; rheumatoid arthritis; serum

Indexed keywords

DIAMINOBENZIDINE; PROGRANULIN; STREPTAVIDIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; BIOLOGICAL MARKER; GRN PROTEIN, HUMAN; SIGNAL PEPTIDE;

AGED; ARTICLE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SCIENCE; HUMAN; IMMUNE RESPONSE; IMMUNOCHEMISTRY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATHOGENESIS; RHEUMATOID ARTHRITIS; SYNOVECTOMY; SYNOVIAL FLUID; SYNOVIUM; UNIVERSITY HOSPITAL; ADULT; ARTHRITIS, RHEUMATOID; BLOOD; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84918817973     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9911-4     Document Type: Article

References (36)

1. Radner, H., J. Smolen, and D. Aletaha. 2012. Performance of the new ACR/EULAR classification criteria for rheumatoid arthritis—a systematic literature review. Arthritis and Rheumatism 64(10): S893–S894.
2. Ravi, B., B. Escott, P.S. Shah, et al. 2012. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis and Rheumatism 64(12): 3839–3849.
3. Tang, W., Y. Lu, Q.-Y. Tian, et al. 2011. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332(6028): 478–484.
4. Liu, C.-J., and X. Bosch. 2012. Progranulin: a growth factor, a novel TNFR ligand and a drug target. Pharmacology & Therapeutics 133(1): 124–132.
5. Zanocco-Marani, T., A. Bateman, G. Romano, B. Valentinis, Z.H. He, and R. Baserga. 1999. Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Research 59(20): 5331–5340.
6. Shoyab, M., V.L. McDonald, C. Byles, G.J. Todaro, and G.D. Plowman. 1990. Epithelin-1 and epithelin-2 - isolation and characterization of 2 cysteine-rich growth-modulating proteins. Proceedings of the National Academy of Sciences of the United States of America 87(20): 7912–7916.
7. Plowman, G.D., J.M. Green, M.G. Neubauer, et al. 1992. The epithelin precursor encodes 2 proteins with opposing activities on epithelial-cell growth. Journal of Biological Chemistry 267(18): 13073–13078.
8. Anakwe, O.O., and G.L. Gerton. 1990. Acrosome biogenesis begins during meiosis—Evidence from the synthesis and distribution of an acrosomal glycoprotein, acrogranin, during guinea-pig spermatogenesis. Biology of Reproduction 42(2): 317–328.
9. Zhou, J., G. Gao, J.W. Crabb, and G. Serrero. 1993. Purification of an autocrine growth-factor homologous with mouse epithelin precursor from a highly tumorigenic cell-line. Journal of Biological Chemistry 268(15): 10863–10869.
10. Hrabal, R., Z.G. Chen, S. James, H.P.J. Bennett, and F. Ni. 1996. The hairpin stack fold, a novel protein architecture for a new family of protein growth factors. Nature Structural Biology 3(9): 747–752.
11. Daniel, R., Z.H. He, K.P. Carmichael, J. Halper, and A. Bateman. 2000. Cellular localization of gene expression for progranulin. Journal of Histochemistry & Cytochemistry 48(7): 999.
12. He, Z.H., C.H.P. Ong, J. Halper, and A. Bateman. 2003. Progranulin is a mediator of the wound response. Nature Medicine 9(2): 225–229.
13. Kessenbrock, K., L. Froehlich, M. Sixt, et al. 2008. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. Journal of Clinical Investigation 118(7): 2438–2447.
14. Zhu, J., C. Nathan, W.W. Jin, et al. 2002. Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair. Cell 111(6): 867–878.
15. Cheung, P.F.Y., C.K.C. Cheng, N.C.L. Wong, et al. 2011. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells. PLoS One 6(12): 12.
16. Guo, F., Y. Lai, Q. Tian, E.A. Lin, L. Kong, and C. Liu. 2010. Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein. Arthritis and Rheumatism 62(7): 2023–2036.
17. Xu, K., Y. Zhang, K. Llalov, et al. 2007. Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation. Journal of Biological Chemistry 282(15): 11347–11355.
18. Liu, C.J. 2011. Progranulin: a promising therapeutic target for rheumatoid arthritis. FEBS Letters 585(23): 3675–3680.
19. Lu, R.Q., and G. Serrero. 2000. Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proceedings of the National Academy of Sciences of the United States of America 97(8): 3993–3998.
20. Lu, R.Q., and G. Serrero. 2001. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor). Proceedings of the National Academy of Sciences of the United States of America 98(1): 142–147.
21. Serrero, G. 2003. Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochemical and Biophysical Research Communications 308(3): 409–413.
22. Tangkeangsirisin, W., J. Hayashi, and G. Serrero. 2004. PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. Cancer Research 64(5): 1737–1743.
23. Serrero, G., K. Tkaczuk, M. Zhan, N. Tait, C. Ilan, and B. Yue. 2009. Elevated serum levels of the growth factor GP88 are found in breast cancer patients when compared to healthy individuals. Cancer Research 69(2): 158S.
24. Abrhale, T., A. Brodie, G. Sabnis, et al. 2011. GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells. BMC Cancer 11.
25. Qiu, F., L. Song, F. Ding, et al. 2013. Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus. Diagnostic Pathology 8.
26. Tanaka, A., H. Tsukamoto, H. Mitoma, et al. 2012. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Arthritis Research & Therapy 14(6).
27. Jian, J., S. Zhao, Q. Tian, et al. 2013. Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. FEBS Letters 587(21): 3428–3436.
28. Guo, Z., Q. Li, Y. Han, Y. Liang, Z. Xu, and T. Ren. 2012. Prevention of LPS-induced acute lung injury in mice by progranulin. Mediators of Inflammation 2012.
29. Egashira, Y., Y. Suzuki, Y. Azuma, et al. 2013. The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. Journal of Neuroinflammation 10.
30. Kawase, R., T. Ohama, A. Matsuyama, et al. 2013. Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice. Cardiovascular Research 100(1): 125–133.
31. Thurner, L., M. Zaks, K.-D. Preuss, et al. 2013. Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis. Arthritis Research & Therapy 15(6).
32. Mattey, D.L., J.R. Glossop, N.B. Nixon, and P.T. Dawes. 2007. Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis. Arthritis and Rheumatism 56(12): 3940–3948.
33. Luo, D., Y. Luo, Y. He, et al. 2006. Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis. American Journal of Pathology 169(5): 1886–1898.
34. Bateman, A., and H.P.J. Bennett. 2009. The granulin gene family: from cancer to dementia. Bioessays 31(11): 1245–1254.
35. Han, J.J., M. Yu, N. Houston, S.M. Steinberg, and E.C. Kohn. 2011. Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers (vol 120, pg 5, 2011). Gynecologic Oncology 121(2): 427.
36. Mackenzie, I.R.A. 2007. The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathologica 114(1): 49–54.